...
首页> 外文期刊>Journal of Clinical Oncology >Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography.
【24h】

Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography.

机译:中性粒细胞性小肠结肠炎在急性白血病患者中:超声检查发现肠壁增厚对预后的意义。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: Neutropenic enterocolitis (NE) is a severe complication of intensive chemotherapy and is barely identifiable by clinical signs alone. Ultrasonography (US) supports the diagnosis of NE by showing pathologic thickening of the bowel wall. The aim of this study was to evaluate the prognostic value of the degree of mural thickening evaluated by US in patients with clinically suspected NE. PATIENTS AND METHODS: Neutropenic patients with fever, diarrhea, and abdominal pain after intensive chemotherapy for hematologic malignancies were studied with abdominal US. We evaluated the degree of bowel wall thickening detected by US and its correlation with the duration of the clinical syndrome as well as NE-related mortality. RESULTS: Eighty-eight (6%) of 1,450 consecutive patients treated for leukemia had clinical signs of NE. In 44 (50%) of 88 patients, US revealed pathologic wall thickening (mean +/- SD, 10.2 +/- 2.9 mm; range, 6 to 18). The mean duration of symptoms was significantly longer in this group (7.9 days) than among patients without mural thickening (3.8 days, P <.0001), and the NE-related mortality rate was higher (29.5% v 0%, P <.001). Patients with bowel wall thickness of more than 10 mm had a significantly higher mortality rate (60%) than did those with bowel wall thickness < or = 10 mm (4.2%, P <.001). CONCLUSION: Symptomatic patients with sonographically detected bowel wall thickening have a poor prognosis compared with patients without this finding. In addition, mural thickness of more than 10 mm is associated with poorer outcome among patients with NE.
机译:目的:中性粒细胞性小肠结肠炎(NE)是强化化疗的严重并发症,仅凭临床体征几乎无法确定。超声检查(US)通过显示肠壁病理性增厚来支持NE的诊断。这项研究的目的是评估由US评估的壁厚增厚程度在临床可疑NE患者中的预后价值。患者和方法:采用腹部超声对强化化疗后血液系统恶性肿瘤发烧,腹泻和腹痛的中性粒细胞减少患者进行了研究。我们评估了US检测到的肠壁增厚程度及其与临床综合征持续时间以及NE相关死亡率的相关性。结果:连续1,450例接受白血病治疗的患者中有88例(6%)有NE的临床体征。在88例患者中有44例(50%),US表现为病理性壁增厚(平均+/- SD,10.2 +/- 2.9 mm;范围6至18)。该组患者的平均症状持续时间(7.9天)比没有壁厚的患者(3.8天,P <.0001)明显更长,并且与NE相关的死亡率更高(29.5%v 0%,P <。 001)。肠壁厚度大于10 mm的患者的死亡率(60%)显着高于肠壁厚度<或= 10 mm的患者(4.2%,P <.001)。结论:经超声检查发现肠壁增厚的有症状患者与无此发现的患者相比,预后较差。此外,NE患者的壁厚超过10 mm与预后差有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号